Journal of Neurology Neurosurgery & Psychiatry · 1980 · 77 citations · 17 references
Life SciencesNeurologyNeuroscienceAutoimmunityImmunopathologyNeuroimmunologyAutoimmune DiseasesAutoimmune Neurological DisordersCentral Nervous System ImmunityDemyelinating DiseasesHumoral ImmunityMultiple SclerosisC3 Complement LevelsCerebrospinal Fluid Antibody ProfilingCerebrospinal Fluid Immunoglobulin ClassesHumoral Immune DysfunctionHumoral Immune Response AlterationsMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis Pathology
The prognosis in multiple sclerosis (MS) is related to the presence of an abnorma humoral immune response within the central nervous system: 14/17 MS patients (82%) without oligoclonal CSF IgG displayed no or slight disability after a mean duration of MS of 17 years, while 53% of 88 patients with oligoclonal CSF IgG had a benign course after a mean duration of 13 years (p less than 0.05). A benign course also was more often accompanied by a normal CSF IgG index. MS patients without oligoclonal CSF IgG had elevated CSF/serum ratios of albumin in 6%, and of the complement factors C3 in 0% and C4 in 6%, as against 20%, 27% and 37%, respectively, in MS patients with oligoclonal CSF IgG.
17
Hans Link, G. Tibbling · Scandinavian Journal of Clinical and Laboratory Investigation · 1977 · 331 citations
H. Link, G. Tibbling · Scandinavian Journal of Clinical and Laboratory Investigation · 1977 · 305 citations
Immunoglobulins in Multiple Sclerosis and Infections of the Nervous System
H. Link, R Müller · Archives of Neurology · 1971 · 295 citations